24 May 2013
Keywords: Merck KGaA, Serono, China, R&D, Investment
Article | 23 November 2009
German drug major Merck KGaA is the latest in a string of multinationals to view China as a good base ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
23 November 2009
20 November 2009
26 November 2009
© 2013 thepharmaletter.com